SCHEMBL113245

SCHEMBL113245

COc1ncc(-c2ccccc2N2CCN(C(C=O)n3nc(C(F)(F)F)cc3C)CC2)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGER Q15109 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP3A5 P20815 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
DHFR P00374 1/20 0.34
SCN9A Q15858 3/20 0.33
GAA P10253 1/20 0.33
HTR1A P08908 3/20 0.33
HTR7 P34969 3/20 0.33
CCR1 P32246 1/20 0.32
CXCR3 P49682 1/20 0.32
KCNH2 Q12809 1/20 0.32
ABL1 P00519 1/20 0.32
CNR1 P21554 1/20 0.32
ALOX5AP P20292 1/20 0.32
FEN1 P39748 1/20 0.32
RAF1 P04049 3/20 0.32
BRAF P15056 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL114268 0.88 CXCR3 (0.40) DHFRHTR1AHTR7CXCR3KCNH2
SCHEMBL114734 0.84 MAPT (0.39) DHFRGAAHTR1AHTR7CXCR3
SCHEMBL115566 0.82 KCNH2 (0.40) AGERCYP3A4CYP3A5HTR1AHTR7
SCHEMBL114717 0.82 ABL1 (0.34) CYP3A4CYP3A5CYP2C9CYP2C19DHFR
SCHEMBL114572 0.80 DHFR (0.33) CYP1A2DHFRHTR1AHTR7CXCR3
SCHEMBL113465 0.80 HTR7 (0.34) DHFRGAAHTR1AHTR7
SCHEMBL114135 0.80 CXCR3 (0.41) GAAHTR1AHTR7CXCR3KCNH2
SCHEMBL113540 0.79 CXCR3 (0.40) CYP3A4CYP1A2CYP2C9CYP2C19DHFR
SCHEMBL115477 0.79 CXCR3 (0.42) DHFRHTR1AHTR7CXCR3KCNH2
SCHEMBL115324 0.78 KCNH2 (0.41) HTR1AHTR7CXCR3KCNH2PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424840-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126811-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed